Evidence map›Paper›PMID 38326514›Full record

ReviewNature reviews. Urology2024

Mechanisms of oxidative stress in interstitial cystitis/bladder pain syndrome.

Ashu Mohammad, Mallory A Laboulaye, Chen Shenhar, Amy D Dobberfuhl

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature reviews. Urology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Bladder cancer risk factors: a comprehensive umbrella review of meta-analyses.International journal of surgery (London, England) · 2026
    Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ashu MohammadDepartment of Urology, Stanford University School of Medicine, Palo Alto, CA, USA.
Mallory A LaboulayeInstitute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA, USA.
Chen ShenharDepartment of Urology, Stanford University School of Medicine, Palo Alto, CA, USA.
Amy D DobberfuhlDepartment of Urology, Stanford University School of Medicine, Palo Alto, CA, USA. adobber@stanford.edu.ORCID 0000-0003-3451-3878

Funding

Improving the Reach and Effectiveness of Smoking Cessation Services Targeted to Veterans Living with HIVR01CA243907 · NCI · SEATTLE INST FOR BIOMEDICAL/CLINICAL RES · PI CROTHERS, KRISTINA ANNE · 2019 to 2025
$3.1M
Signal integration by specialized mesenchyme in urothelial homeostasis and Interstitial Cystitis / Bladder Pain SyndromeR01DK134989 · NIDDK · STANFORD UNIVERSITY · PI BEACHY, PHILIP A · 2022 to 2025
$3.0M
Validation of a Neurogenic Bladder Management Solution to Promote Independence and Reduce Long-Term Morbidity for Patients Unable to Perform Intermittent CatheterizationR44DK127580 · NIDDK · CRM MEDICAL DEVICES, INC. · PI ELLIOTT, CHRISTOPHER, EVERSULL, CHRISTIAN S · 2022 to 2023
$1.5M
NCI NIH HHS R01 CA243907NIDDK NIH HHS R01 DK134989NIDDK NIH HHS R44 DK127580
6 · The paper itself

Abstract

Interstitial cystitis/bladder pain syndrome (IC/BPS) is characterized by bladder and/or pelvic pain, increased urinary urgency and frequency and nocturia. The pathophysiology of IC/BPS is poorly understood, and theories include chronic inflammation, autoimmune dysregulation, bacterial cystitis, urothelial dysfunction, deficiency of the glycosaminoglycan (GAG) barrier and urine cytotoxicity. Multiple treatment options exist, including behavioural interventions, oral medications, intravesical instillations and procedures such as hydrodistension; however, many clinical trials fail, and patients experience an unsatisfactory treatment response, likely owing to IC/BPS phenotype heterogeneity and the use of non-targeted interventions. Oxidative stress is implicated in the pathogenesis of IC/BPS as reactive oxygen species impair bladder function via their involvement in multiple molecular mechanisms. Kinase signalling pathways, nociceptive receptors, mast-cell activation, urothelial dysregulation and circadian rhythm disturbance have all been linked to reactive oxygen species and IC/BPS. However, further research is necessary to fully uncover the role of oxidative stress in the pathways driving IC/BPS pathogenesis. The development of new models in which these pathways can be manipulated will aid this research and enable further investigation of promising therapeutic targets.

Indexed as

Cystitis, InterstitialOxidative StressAnimalsHumansReactive Oxygen SpeciesReactive Oxygen Species

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.